[ad_1]
“It would probably be a dream to say that we travel as much as we want, but we also understand that the group of people who should register is probably very large, so we are still consulting with the municipalities a bit now, how they would see this process,” said the Friday the vice minister.
“It seems like we’re inclined to recommend the registry for seniors first, maybe every five years, but exactly how we’ll implement it is probably another week and we’ll finally have those answers next week,” he said. added.
First of all, we seem to be inclined to recommend registration to older people.
According to the deputy minister, it is still difficult to say exactly when the mass vaccination will begin, because even after the vaccination of the elderly is completed, there would be two more priority groups: people with chronic diseases and employees who perform important functions in the state. . . Registration of these groups for vaccination is planned to take place through workplaces and medical institutions.
“We are talking about the start of mass vaccination at the beginning of May. We can talk about the vaccination of these groups, people with chronic diseases and who perform important functions for the state and society, during the second half of March to April,” he said. Ž.Simonaitytė.
The priority list of patients to be vaccinated was compiled by the ministry last year, and it is planned to update it with disease codes in the near future, but according to the deputy minister, there will be “more technical changes.” .
Registration will be done through e-health
It is expected that after the start of mass vaccination of society, its population will be registered through the e-health system. The vice minister recognizes that this will be a challenge that is already being prepared with the update of this system and the deployment of additional capacities.
Currently, the Registration Center is working on updating the pre-patient registration system and it is planned that this will be done either by connecting residents to the system or by calling and registering, but using the e-health system that manages the Registry. Center, “said Ž.Simonaitytė.
For its part, the Registry Center informed BNS that “an eHealth system, like any other computer system, can be a challenge at the same time.”
“However, it can be managed by distributing the flow of applicants evenly, for example, differentiating the process by age group. As usual, there is regular communication with the system administrator, the Ministry of Health, on this and other issues related to e-health, ”said Mindaugas Samkus, representative of the Registry Center.
Photo by Lukas Balandis / 15min / Živilė Simonaitytė
According to her, a backup log system is currently being developed, which would be used in case of problems.
The registry center system was chosen for this purpose because most health institutions have interfaces with e-health, which makes the registry easier to implement technologically.
“Of course, if there is a need, and the backup system I mentioned you will get it from private providers and you will have that backup registration package,” he said.
Vaccination sites may increase
Speaking of the “live tail” for vaccines that are not used immediately, the deputy minister said that so far there is no such problem that vaccines are not used, because they can be stored for another five days after thawing.
“If it happens that some vaccines are not used that day, they are used the next day. The fact is, of course, that with increasing volumes, increasing amounts of thaw vaccines that must be consumed, if we are faced with such a need, it can be done. “, He said.
According to Ž.Simonaitytė, it is also being considered that in the future vaccination could take place not only in pharmacies, but also at mobile points.
“There are really many opportunities to expand vaccination sites, if we see the need to not be able to use those vaccines, then we will expand,” said the deputy minister.
He stressed that, as in the past in a hospital emergency, the key issue is not infrastructure but human resources, that is, the people who can carry out the vaccination.
The Ministry also plans to expand the information campaign for the population, as well as to publish more information in other languages, such as Russian or Polish.
Current vaccination rates are sufficient
“Based on the current quantities of vaccines available, we see that, in general, those rates are satisfying us and we do not see the need to work on holidays or weekends, or to work very intensively as we do on the days. normal work, “she said.
However, according to her, this may change with the increase in the amount of vaccine delivered, so the ministry is in contact with the municipalities and they are preparing to organize vaccination in the future not only during the week.
Kaunas City Municipality Photo / The largest vaccination center in the country has been inaugurated in Kaunas
As of last Friday, March 5, at most, more than 12 thousand. people were vaccinated this Wednesday. At that time, there was no vaccination at all on Sunday. More than 400 people were vaccinated every Saturday and holiday Thursday.
In Lithuania, vaccination with AstraZeneca is successful
“There is no science-based reason to stop vaccination (AstraZeneca – BNS vaccine) at this time,” Simonaitytė said.
According to her, there have been no confirmed reports of dangerous side effects from this vaccine.
“The European Medicines Agency (EMA) has released information that one or another case currently does not give any reason to believe that it is specifically related to vaccination,” said the deputy minister.
According to her, the Minister of Health Arūnas Dulkys consulted with the representatives of the European Commission responsible for the vaccination processes, the Health Ministers of Germany and Greece on this issue and agreed that the data approved by the EEA should be followed.
Ž.Simonaitytė said that vaccination with the AstraZeneca vaccine is successful in Lithuania.
“Looking at the data, we may have seen slower input from AstraZaneca, but now we don’t see any major problems with the vaccine,” he said.
Scanpix Photo / COVID-19 Vaccines
“Of course, if we see that one or another priority group does not want this vaccine, we can consider other possibilities of using this vaccine (BNS for other groups). But so far we have no reason to do so, because we see that vaccination with it it is quite successful, ”said the deputy minister.
Denmark, Norway and Iceland temporarily stopped receiving the AstraZeneca vaccine this week after noticing blood clots in some people after the vaccine. Experts emphasize that the decision is preventive, since a causal link between the vaccine and these disorders has not yet been established.
Austria, Latvia, Lithuania and Luxembourg discontinued vaccination with one batch of the vaccine, following reports from Austria that a 49-year-old nurse had died from increased blood clotting after vaccination, and another woman had a pulmonary embolism . The European Medicines Agency (EMA) has already ruled out that this could be related to the vaccine.
In total, as of March 9, the EVA had received 22 reports of blood clots in vaccinated people.
Currently, three COVID-19 vaccines approved by the European Medicines Agency are used in Lithuania: Pfizer and BioNTech, Moderna and AstraZeneca. The Johnson & Johnson vaccine is being prepared for use by EVA on Thursday.
If you have any questions about the COVID-19 vaccine, please send them to our editorial staff by email. email address [email protected]
[ad_2]
